companiesSEC EDGAR
Protalix BioTherapeutics, Inc.
SEC EDGAR published this disclosure on 2026-08-12. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001104659-26-094444
cik1006281
company nameProtalix BioTherapeutics, Inc.
form10-Q